Related Experiment Video
Updated: Jan 9, 2026

05:35
Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
Published on: June 6, 2025
1.2K
Development and External Validation of a Nomogram for Predicting Pain Risk Post-Transperineal Prostate Biopsy Using
Yang Xu1, Xin Li2, Yang Zhang1
1Department of Urology, The Affiliated Lianyungang Hospital of Xuzhou Medical University/The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, 222000, People's Republic of China.
Journal of Pain Research
|December 11, 2025
Summary
A new nomogram effectively predicts moderate-to-severe pain after prostate biopsy (TPB). This tool aids personalized pain management by identifying risk factors like prostate volume and anxiety, improving patient outcomes.
Area of Science:
- Urology
- Pain Management
- Medical Informatics
Background:
- Ultrasound-guided transperineal prostate biopsy (TPB) is a common procedure.
- Managing moderate-to-severe pain (NRS > 4) post-TPB is crucial for patient comfort and adherence.
- Predictive models for pain are needed to guide perioperative management.
Purpose of the Study:
- To identify factors associated with moderate-to-severe pain following TPB.
- To develop and validate a nomogram model for assessing TPB-related pain risk.
- To establish a tool for personalized pain management strategies.
Main Methods:
- A cohort of 520 patients undergoing TPB was divided into training (n=400) and validation (n=120) groups.
- Binary logistic regression identified risk factors for moderate-to-severe pain.
- A nomogram risk assessment model was constructed and validated internally and externally.
Main Results:
- Prostate volume, anxiety score, diabetes history, biopsy time, and needle count were significant risk factors.
- Age was identified as a protective factor against pain.
- The nomogram demonstrated high predictive accuracy (AUC 0.940 training, 0.893 internal validation, 0.888 external validation).
Conclusions:
- The developed nomogram is a robust tool for stratifying patients at risk of moderate-to-severe pain after TPB.
- The model's strong performance across internal and external validation supports its clinical applicability.
- This risk stratification tool facilitates personalized perioperative pain management for TPB patients.

